Literature DB >> 20674001

The relationship between terminal functionalization and molecular weight of a gene delivery polymer and transfection efficacy in mammary epithelial 2-D cultures and 3-D organotypic cultures.

Nupura S Bhise1, Ryan S Gray, Joel C Sunshine, Soe Htet, Andrew J Ewald, Jordan J Green.   

Abstract

Non-viral gene delivery vectors were developed for efficient gene transfer to hard-to-transfect mouse mammary epithelial cells. Ten modified versions of the same base poly(beta-amino ester), poly(1,4-butanediol diacrylate-co-5-amino-1-pentanol), were tested in both traditional 2-D monolayer and in 3-D organotypic cultures. The polymers self-assembled with plasmid DNA encoding enhanced green fluorescent protein to form nanoparticles (approximately 100 nm) used to transfect the cells. Nanoparticle transfection efficacy was tuned by changes in synthesis and fabrication conditions and the transfection efficacy was analyzed using confocal microscopy and flow cytometry. The best performing polymeric nanoparticles transfected 57 +/- 6% of the cells in 2-D culture and 6 +/- 1% of the cells in 3-D culture. Small modifications to the polymer end-capping molecules and tuning of polymer molecular weight could either significantly enhance the transfection efficacy up to 6-fold or instead abolish efficacy completely. The efficacy of leading polymers was higher than that of the commercial transfection agent FuGENE HD by a factor of 13 in 2-D and 2 in 3-D. These non-viral nanoparticles may be useful as delivery reagents or targeted therapeutics for breast cancer. This gene delivery strategy is also a promising approach for studying the normal development of the mammary gland. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674001      PMCID: PMC3175420          DOI: 10.1016/j.biomaterials.2010.07.023

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  47 in total

1.  a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.

Authors:  F R Khuri; J Nemunaitis; I Ganly; J Arseneau; I F Tannock; L Romel; M Gore; J Ironside; R H MacDougall; C Heise; B Randlev; A M Gillenwater; P Bruso; S B Kaye; W K Hong; D H Kirn
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

2.  Gene therapy put on hold as third child develops cancer.

Authors:  Erika Check
Journal:  Nature       Date:  2005-02-10       Impact factor: 49.962

3.  Optimising non-viral gene delivery in a tumour spheroid model.

Authors:  H R Mellor; L A Davies; H Caspar; C R Pringle; S C Hyde; D R Gill; R Callaghan
Journal:  J Gene Med       Date:  2006-09       Impact factor: 4.565

4.  ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells.

Authors:  Thomas Waerner; Memetcan Alacakaptan; Ido Tamir; Rupert Oberauer; Annamaria Gal; Thomas Brabletz; Martin Schreiber; Martin Jechlinger; Hartmut Beug
Journal:  Cancer Cell       Date:  2006-09       Impact factor: 31.743

Review 5.  Liver tissue engineering in the evaluation of drug safety.

Authors:  Ajit Dash; Walker Inman; Keith Hoffmaster; Samantha Sevidal; Joan Kelly; R Scott Obach; Linda G Griffith; Steven R Tannenbaum
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-10       Impact factor: 4.481

6.  Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery.

Authors:  Jae-Seung Lee; Jordan J Green; Kevin T Love; Joel Sunshine; Robert Langer; Daniel G Anderson
Journal:  Nano Lett       Date:  2009-06       Impact factor: 11.189

7.  T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

Authors:  R M Blaese; K W Culver; A D Miller; C S Carter; T Fleisher; M Clerici; G Shearer; L Chang; Y Chiang; P Tolstoshev; J J Greenblatt; S A Rosenberg; H Klein; M Berger; C A Mullen; W J Ramsey; L Muul; R A Morgan; W F Anderson
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

8.  Cationic star polymers consisting of alpha-cyclodextrin core and oligoethylenimine arms as nonviral gene delivery vectors.

Authors:  Chuan Yang; Hongzhe Li; Suat Hong Goh; Jun Li
Journal:  Biomaterials       Date:  2007-04-12       Impact factor: 12.479

9.  The MAPK(ERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium.

Authors:  Jimmie E Fata; Hidetoshi Mori; Andrew J Ewald; Hui Zhang; Evelyn Yao; Zena Werb; Mina J Bissell
Journal:  Dev Biol       Date:  2007-03-16       Impact factor: 3.582

10.  A global double-fluorescent Cre reporter mouse.

Authors:  Mandar Deepak Muzumdar; Bosiljka Tasic; Kazunari Miyamichi; Ling Li; Liqun Luo
Journal:  Genesis       Date:  2007-09       Impact factor: 2.487

View more
  41 in total

1.  A novel assay for quantifying the number of plasmids encapsulated by polymer nanoparticles.

Authors:  Nupura S Bhise; Ron B Shmueli; Jose Gonzalez; Jordan J Green
Journal:  Small       Date:  2011-12-05       Impact factor: 13.281

2.  Effects of trehalose polycation end-group functionalization on plasmid DNA uptake and transfection.

Authors:  Kevin Anderson; Antons Sizovs; Mallory Cortez; Chris Waldron; D M Haddleton; Theresa M Reineke
Journal:  Biomacromolecules       Date:  2012-07-18       Impact factor: 6.988

3.  Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours.

Authors:  Johan Karlsson; Yuan Rui; Kristen L Kozielski; Amanda L Placone; Olivia Choi; Stephany Y Tzeng; Jayoung Kim; Jamal J Keyes; Max I Bogorad; Kathleen Gabrielson; Hugo Guerrero-Cazares; Alfredo Quiñones-Hinojosa; Peter C Searson; Jordan J Green
Journal:  Nanoscale       Date:  2019-10-15       Impact factor: 7.790

4.  A549 and MRC-5 cell aggregation in a microfluidic Lab-on-a-chip system.

Authors:  A Zuchowska; E Jastrzebska; K Zukowski; M Chudy; A Dybko; Z Brzozka
Journal:  Biomicrofluidics       Date:  2017-03-28       Impact factor: 2.800

Review 5.  Targeted polymeric nanoparticles for cancer gene therapy.

Authors:  Jayoung Kim; David R Wilson; Camila G Zamboni; Jordan J Green
Journal:  J Drug Target       Date:  2015-06-10       Impact factor: 5.121

Review 6.  Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities.

Authors:  Carolyn L Waite; Charles M Roth
Journal:  Crit Rev Biomed Eng       Date:  2012

7.  Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties.

Authors:  Joel C Sunshine; Daniel Y Peng; Jordan J Green
Journal:  Mol Pharm       Date:  2012-09-27       Impact factor: 4.939

8.  Differential polymer structure tunes mechanism of cellular uptake and transfection routes of poly(β-amino ester) polyplexes in human breast cancer cells.

Authors:  Jayoung Kim; Joel C Sunshine; Jordan J Green
Journal:  Bioconjug Chem       Date:  2013-12-20       Impact factor: 4.774

Review 9.  Organ-on-a-chip platforms for studying drug delivery systems.

Authors:  Nupura S Bhise; João Ribas; Vijayan Manoharan; Yu Shrike Zhang; Alessandro Polini; Solange Massa; Mehmet R Dokmeci; Ali Khademhosseini
Journal:  J Control Release       Date:  2014-05-10       Impact factor: 9.776

10.  Evaluation of polymeric gene delivery nanoparticles by nanoparticle tracking analysis and high-throughput flow cytometry.

Authors:  Ron B Shmueli; Nupura S Bhise; Jordan J Green
Journal:  J Vis Exp       Date:  2013-03-01       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.